StartupsFinSMEsabout 10 hours ago
Ollin Biosciences Raises $330M in Series B Funding
1 min read
Ollin Biosciences closed a $330 million Series B funding round. The financing supports the company's development of precision gene-editing therapies for rare genetic diseases. The round represents one of the largest private biotech fundraises this year.
Level
Hype check
Tap to vote and see what everyone thinks.
